USD 0.0
(-10.53%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 2.33 Million USD | 6.27% |
2023 | 2.19 Million USD | -28.19% |
2022 | 3.05 Million USD | 21.88% |
2021 | 2.5 Million USD | 15.13% |
2020 | 2.17 Million USD | 11.47% |
2019 | 1.95 Million USD | 0.0% |
2013 | 1.71 Million USD | 47.6% |
2012 | 1.16 Million USD | 1024.98% |
2011 | 103.56 Thousand USD | 327.41% |
2010 | 24.23 Thousand USD | 156.55% |
2009 | 9445.00 USD | 43.28% |
2008 | 6592.00 USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 FY | 2.33 Million USD | 6.27% |
2024 Q1 | 2.27 Million USD | 3.51% |
2024 Q2 | 2.27 Million USD | -0.04% |
2024 Q3 | 2.25 Million USD | -0.69% |
2024 Q4 | 2.33 Million USD | 3.42% |
2023 Q3 | 2.12 Million USD | 0.23% |
2023 Q2 | 2.12 Million USD | -32.73% |
2023 FY | 2.19 Million USD | -28.19% |
2023 Q1 | 3.15 Million USD | 0.0% |
2023 Q4 | 2.19 Million USD | 3.17% |
2022 FY | 3.05 Million USD | 21.88% |
2021 FY | 2.5 Million USD | 15.13% |
2020 FY | 2.17 Million USD | 11.47% |
2019 FY | 1.95 Million USD | 0.0% |
2013 FY | 1.71 Million USD | 47.6% |
2013 Q4 | 1.78 Million USD | 1.05% |
2013 Q3 | 1.76 Million USD | 1.22% |
2013 Q1 | 1.71 Million USD | -26.78% |
2013 Q2 | 1.74 Million USD | 1.29% |
2012 Q2 | 1.33 Million USD | 14.15% |
2012 FY | 1.16 Million USD | 1024.98% |
2012 Q4 | 2.34 Million USD | 15.37% |
2012 Q3 | 2.03 Million USD | 53.06% |
2012 Q1 | 1.16 Million USD | 40.37% |
2011 FY | 103.56 Thousand USD | 327.41% |
2011 Q1 | 103.56 Thousand USD | 155.72% |
2011 Q2 | 155 Thousand USD | 49.66% |
2011 Q3 | 505 Thousand USD | 225.81% |
2011 Q4 | 830 Thousand USD | 64.36% |
2010 Q2 | 30.58 Thousand USD | 26.22% |
2010 Q1 | 24.23 Thousand USD | 30.62% |
2010 FY | 24.23 Thousand USD | 156.55% |
2010 Q4 | 40.5 Thousand USD | 21.07% |
2010 Q3 | 33.45 Thousand USD | 9.38% |
2009 FY | 9445.00 USD | 43.28% |
2009 Q4 | 18.55 Thousand USD | -13.35% |
2009 Q3 | 21.4 Thousand USD | 146.25% |
2009 Q2 | 8694.00 USD | -7.95% |
2009 Q1 | 9445.00 USD | 36.0% |
2008 FY | 6592.00 USD | 0.0% |
2008 Q3 | 5445.00 USD | -75.17% |
2008 Q2 | 21.92 Thousand USD | 0.0% |
2008 Q4 | 6945.00 USD | 27.55% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Energy Corporation | 4.34 Million USD | 46.366% |
Earth Alive Clean Technologies Inc. | 994.33 Thousand USD | -134.487% |
Igene Biotechnology, Inc. | 7.5 Million USD | 68.922% |
Lotus Bio-Technology Development Corp. | - USD | -Infinity% |
MagIndustries Corp. | 99.83 Million USD | 97.664% |
Itafos Inc. | 346.68 Million USD | 99.327% |
Yara International ASA | 8.45 Billion USD | 99.972% |
Yara International ASA | 8.43 Billion USD | 99.972% |